Authors

Yazmin Odia, Miami Cancer InstituteFollow
Minesh Mehta, Miami Cancer InstituteFollow

A Phase 1/2 Study of Selinexor in Combination with Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma

Publication Date

6-2021

Presented At:

2021 ASCO Annual Meeting

Content Type

Presentation

Publisher's Site:

View at Publisher Website

Additional Authors:

Additional authors and institutional affiliations

Citation

Odia, Yazmin and Mehta, Minesh, "A Phase 1/2 Study of Selinexor in Combination with Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma" (2021). All Publications. 4007.
https://scholarlycommons.baptisthealth.net/se-all-publications/4007